Gene Therapy Clinical Trial Services Market Size

Gene Therapy Clinical Trial Services Market Size

Gene Therapy Clinical Trial Services Market size was valued at USD 1.1 billion in 2023 and is estimated to grow at 9.2% CAGR from 2024 to 2032. The market has witnessed significant expansion attributed to the global rise in genetic disorders and chronic diseases.

The growing focus on genetic mechanisms has intensified efforts toward developing gene-based therapies for previously non-curable conditions. This has prompted substantial investments in gene therapy clinical trials by pharmaceutical and biotech companies, and academic institutions, thereby spurring the demand for specialized services. For instance, by the end of 2023, there was a global launch of 76 cell and gene therapies, accounting more than double the number in 2013. This show an escalated research activities and clinical studies. Thus, widespread adoption of clinical trial services in gene therapy sector will foster the market growth.
 

Gene therapy clinical trial services refer to a comprehensive range of specialized services provided throughout the various stages of clinical trials aimed at evaluating the safety, efficacy, and feasibility of gene therapy interventions. These services include trial design, patient recruitment, regulatory compliance, data management, monitoring, and manufacturing support tailored to meet the unique requirements of gene therapy research protocols.